Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Genocea Biosciences (GNCA)
Revenue in 2022 (TTM): $1.91 M
According to Genocea Biosciences 's latest financial reports the company's current revenue (TTM) is $1.91 M. In 2021 the company made a revenue of $1.64 M an increase over the years 2020 revenue that were of $1.35 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genocea Biosciences from 2013 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $1.91 M | 16.45% |
| 2021 | $1.64 M | 20.75% |
| 2020 | $1.35 M | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | -100% |
| 2016 | $0.23 M | -64.93% |
| 2015 | $0.67 M | 117.53% |
| 2014 | $0.3 M | -57.87% |
| 2013 | $0.73 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $58.49 B | 3,060,967.50% | 🇺🇸 USA |
 Merck MRK | $60.11 B | 3,145,582.89% | 🇺🇸 USA |
 Novavax NVAX | $0.69 B | 36,187.86% | 🇺🇸 USA |
 Agenus
AGEN | $0.15 B | 8,079.64% | 🇺🇸 USA |
 iBio IBIO | $0.05 M | -97.38% | 🇺🇸 USA |